{"id":353930,"date":"2025-08-28T10:27:19","date_gmt":"2025-08-28T10:27:19","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-charles-river-laboratories-international\/"},"modified":"2025-08-28T10:27:19","modified_gmt":"2025-08-28T10:27:19","slug":"how-to-buy-charles-river-laboratories-international","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","title":{"rendered":"How to buy Charles River Laboratories International, Inc. (CRL) shares &#8211; Investment in Charles River Laboratories International, Inc. (CRL) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-353930","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Charles River Laboratories International, Inc. (CRL) Shares - Investment in Charles River Laboratories International, Inc. (CRL) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Charles River Laboratories International, Inc. (CRL) Shares - Investment in Charles River Laboratories International, Inc. (CRL) Stock"},"description":"Learn how to buy Charles River Laboratories International (CRL) stock with our comprehensive investment analysis. Discover current price, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Charles River Laboratories International (CRL) stock with our comprehensive investment analysis. Discover current price, risks, and growth potential for 2025-2030."},"intro":"Thinking about investing in a company that touches 80% of FDA-approved drugs? Charles River Laboratories (CRL) is the invisible backbone of modern medicine\u2014a contract research organization that helps pharmaceutical giants bring life-saving treatments to market. This isn't just another stock; it's a stake in the future of healthcare innovation.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in a company that touches 80% of FDA-approved drugs? Charles River Laboratories (CRL) is the invisible backbone of modern medicine\u2014a contract research organization that helps pharmaceutical giants bring life-saving treatments to market. This isn't just another stock; it's a stake in the future of healthcare innovation."},"body_html":"<h2>\ud83d\udcc8 CRL Stock Analysis: Current Price and Market Position<\/h2> <p>As of August 28, 2025, Charles River Laboratories International (CRL) trades at <strong>$159.58<\/strong> on the NYSE. The company just delivered a stellar Q2 earnings beat, reporting $3.12 EPS versus the expected $2.50\u2014a massive 24.80% surprise that sent shares climbing 4% in premarket trading.<\/p> <p><strong>Mark Your Calendar: November 5, 2025<\/strong><br> This is your next critical date. Charles River reports Q3 2025 earnings before market open. Historically, these reports create significant price movements. Look what happened last time:<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 6, 2025<\/td><td>Q2 Earnings<\/td><td>$155.00<\/td><td>+4% (immediate)<\/td><\/tr> <tr><td>May 8, 2025<\/td><td>Q1 Earnings<\/td><td>$148.50<\/td><td>+3.2% (week)<\/td><\/tr> <tr><td>Feb 2025<\/td><td>Annual Results<\/td><td>$142.00<\/td><td>+5.8% (beat)<\/td><\/tr> <tr><td>Nov 2024<\/td><td>Partnership News<\/td><td>$138.75<\/td><td>+4.1% (3 days)<\/td><\/tr> <tr><td>Aug 2024<\/td><td>Q2 2024<\/td><td>$135.20<\/td><td>-2.9% (miss)<\/td><\/tr> <\/tbody> <\/table> <p>The pattern is clear: positive earnings surprises drive immediate gains, while misses create buying opportunities for patient investors.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster with Purpose<\/h2> <p>CRL has been on quite the ride these past six months:<\/p> <ul> <li><strong>February 2025<\/strong>: $142.00 (post-holiday stability)<\/li> <li><strong>March 2025<\/strong>: $136.50 (FDA regulation concerns)<\/li> <li><strong>April 2025<\/strong>: $148.00 (+6.81% surge on research news)<\/li> <li><strong>May 2025<\/strong>: $152.75 (Q1 earnings momentum)<\/li> <li><strong>July 2025<\/strong>: $157.20 (summer consolidation)<\/li> <li><strong>August 2025<\/strong>: $159.58 (Q2 earnings boost)<\/li> <\/ul> <p>That's a <strong>12.4% gain<\/strong> over six months\u2014not spectacular, but steady growth despite sector headwinds. The stock demonstrated resilience, bouncing back from March lows when FDA animal testing reduction plans spooked investors.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and company fundamentals:<\/p> <ul> <li><strong>2025 Year-End<\/strong>: $175-190 (10-19% upside from current)<br> <em>Rationale: Strong contract flow + raised profit guidance<\/em><\/li> <li><strong>2026 Target<\/strong>: $200-225 (25-41% growth potential)<br> <em>Rationale: Market recovery + expanded service offerings<\/em><\/li> <li><strong>2028 Projection<\/strong>: $280-320 (75-100% long-term gain)<br> <em>Rationale: Biotech boom + aging population demand<\/em><\/li> <li><strong>2030 Vision<\/strong>: $400-450 (150-180% total return)<br> <em>Rationale: Global healthcare expansion + AI integration<\/em><\/li> <\/ul> <p><strong>Verdict: STRONG BUY<\/strong> for long-term investors. The recent earnings beat and raised guidance signal management confidence despite short-term volatility.<\/p>  <h2>\u26a0\ufe0f Risk Assessment: What Could Go Wrong?<\/h2> <ul> <li><strong>Regulatory Risks<\/strong>: FDA's plan to reduce animal testing could impact 30% of revenue from Discovery &amp; Safety Assessment segment. This isn't hypothetical\u2014it's already causing analyst downgrades.<\/li> <li><strong>Client Concentration<\/strong>: Major pharmaceutical budget cuts or mergers could reduce contract volumes. When big pharma sneezes, CROs catch colds.<\/li> <li><strong>Currency Exposure<\/strong>: 68% revenue from overseas means strong dollar hurts international profits.<\/li> <li><strong>Debt Concerns<\/strong>: $2.1 billion debt load requires careful cash flow management during economic uncertainty.<\/li> <\/ul>  <h2>\ud83d\udfe2 Positive Signals: Why CRL Could Soar<\/h2> <ul> <li><strong>Earnings Momentum<\/strong>: Q2 2025 beat by 24.80% shows operational excellence<\/li> <li><strong>Contract Wins<\/strong>: Multiple large-scale renewals with global biopharma clients<\/li> <li><strong>Industry Trend<\/strong>: Outsourced research growing at 8% annually as pharma cuts costs<\/li> <li><strong>Digital Transformation<\/strong>: Lab automation investments improving margins<\/li> <li><strong>Defensive Business<\/strong>: Essential services regardless of economic conditions<\/li> <\/ul>  <h2>\ud83d\udcf0 Recent News Impact: August 2025 Analysis<\/h2> <p>Charles River has been busy in 2025! The company secured several strategic partnerships, including an expanded collaboration with a leading biotech firm to develop advanced drug development models. These deals aren't just press releases\u2014they represent future revenue streams that could drive growth for years.<\/p> <p>Most importantly, management reaffirmed full-year guidance despite macroeconomic challenges. When executives put their reputation behind forecasts during uncertain times, it's usually a good sign.<\/p>  <h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2> <ol> <li><strong>Start Small<\/strong>: Buy 1-2 shares to get skin in the game without overexposure<\/li> <li><strong>Dollar-Cost Average<\/strong>: Add $100 monthly regardless of price fluctuations<\/li> <li><strong>Set Price Alerts<\/strong>: Buy more if stock drops to $150 support level<\/li> <li><strong>Patience Pays<\/strong>: This is a 3-5 year investment, not a weekly trade<\/li> <li><strong>Humorous Reality Check<\/strong>: \"Trading CRL is like watching paint dry\u2014until suddenly it's a masterpiece. Bring snacks.\"<\/li> <\/ol>  <h2>\u2705 How to Buy Charles River Laboratories International, Inc. (CRL) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose Trading Platform<\/td><td>Ensure it offers NYSE stocks and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Complete Account Funding<\/td><td>Start with $50-100 to test waters<\/td><\/tr> <tr><td>3<\/td><td>Search \"CRL\"<\/td><td>Use ticker symbol, not company name<\/td><\/tr> <tr><td>4<\/td><td>Select Order Type<\/td><td>Use limit order around $158-161 for better entry<\/td><\/tr> <tr><td>5<\/td><td>Review and Execute<\/td><td>Check commission fees\u2014aim for &lt;1% transaction cost<\/td><\/tr> <tr><td>6<\/td><td>Set Portfolio Allocation<\/td><td>Keep CRL at 5-10% of total portfolio for diversification<\/td><\/tr> <tr><td>7<\/td><td>Enable Price Alerts<\/td><td>Get notified at key support\/resistance levels<\/td><\/tr> <tr><td>8<\/td><td>Document Your Thesis<\/td><td>Write down why you bought for future reference<\/td><\/tr> <tr><td>9<\/td><td>Regular Review<\/td><td>Check quarterly earnings, not daily price movements<\/td><\/tr> <tr><td>10<\/td><td>Reinvest Dividends<\/td><td>CRL doesn't pay dividends, but plan for compounding<\/td><\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Makes Sense for CRL Investors<\/h2> <p>Pocket Option offers unique advantages for Charles River Laboratories investors:<\/p> <ul> <li><strong>Minimum Deposit Just $5<\/strong> - Perfect for testing strategies with small positions<\/li> <li><strong>Lightning-Fast KYC<\/strong> - Upload any ID document and start trading in minutes<\/li> <li><strong>100+ Withdrawal Methods<\/strong> - Crypto, e-wallets, bank cards\u2014your profit, your choice<\/li> <li><strong>Fractional Shares Available<\/strong> - Buy pieces of CRL without full share price<\/li> <li><strong>Real-Time NYSE Data<\/strong> - Accurate pricing for informed decisions<\/li> <\/ul> <p>For new investors, this accessibility means you can build a position in CRL gradually without needing thousands upfront.<\/p>  <h2>\ud83c\udf0d Charles River Laboratories in 2025: The Invisible Pharma Giant<\/h2> <p>Charles River isn't a household name, but it should be. This company has been involved in <strong>80% of FDA-approved drugs<\/strong> over the past five years\u2014that's virtually every major medication reaching patients. Founded in 1947, CRL has evolved from animal research provider to comprehensive drug development partner serving pharmaceutical giants worldwide.<\/p> <p>The company operates three core segments: Research Models &amp; Services, Discovery &amp; Safety Assessment, and Manufacturing Support. Their 20,100 employees work across global laboratories, helping accelerate treatments for everything from cancer to rare diseases.<\/p> <p><strong>2025 Interesting Fact<\/strong>: Charles River's scientists recently developed a breakthrough AI-powered drug discovery platform that can predict compound effectiveness with 92% accuracy\u2014cutting research time from years to months and potentially saving billions in development costs.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 CRL Stock Analysis: Current Price and Market Position<\/h2>\n<p>As of August 28, 2025, Charles River Laboratories International (CRL) trades at <strong>$159.58<\/strong> on the NYSE. The company just delivered a stellar Q2 earnings beat, reporting $3.12 EPS versus the expected $2.50\u2014a massive 24.80% surprise that sent shares climbing 4% in premarket trading.<\/p>\n<p><strong>Mark Your Calendar: November 5, 2025<\/strong><br \/> This is your next critical date. Charles River reports Q3 2025 earnings before market open. Historically, these reports create significant price movements. Look what happened last time:<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 6, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$155.00<\/td>\n<td>+4% (immediate)<\/td>\n<\/tr>\n<tr>\n<td>May 8, 2025<\/td>\n<td>Q1 Earnings<\/td>\n<td>$148.50<\/td>\n<td>+3.2% (week)<\/td>\n<\/tr>\n<tr>\n<td>Feb 2025<\/td>\n<td>Annual Results<\/td>\n<td>$142.00<\/td>\n<td>+5.8% (beat)<\/td>\n<\/tr>\n<tr>\n<td>Nov 2024<\/td>\n<td>Partnership News<\/td>\n<td>$138.75<\/td>\n<td>+4.1% (3 days)<\/td>\n<\/tr>\n<tr>\n<td>Aug 2024<\/td>\n<td>Q2 2024<\/td>\n<td>$135.20<\/td>\n<td>-2.9% (miss)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern is clear: positive earnings surprises drive immediate gains, while misses create buying opportunities for patient investors.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: Rollercoaster with Purpose<\/h2>\n<p>CRL has been on quite the ride these past six months:<\/p>\n<ul>\n<li><strong>February 2025<\/strong>: $142.00 (post-holiday stability)<\/li>\n<li><strong>March 2025<\/strong>: $136.50 (FDA regulation concerns)<\/li>\n<li><strong>April 2025<\/strong>: $148.00 (+6.81% surge on research news)<\/li>\n<li><strong>May 2025<\/strong>: $152.75 (Q1 earnings momentum)<\/li>\n<li><strong>July 2025<\/strong>: $157.20 (summer consolidation)<\/li>\n<li><strong>August 2025<\/strong>: $159.58 (Q2 earnings boost)<\/li>\n<\/ul>\n<p>That&#8217;s a <strong>12.4% gain<\/strong> over six months\u2014not spectacular, but steady growth despite sector headwinds. The stock demonstrated resilience, bouncing back from March lows when FDA animal testing reduction plans spooked investors.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and company fundamentals:<\/p>\n<ul>\n<li><strong>2025 Year-End<\/strong>: $175-190 (10-19% upside from current)<br \/> <em>Rationale: Strong contract flow + raised profit guidance<\/em><\/li>\n<li><strong>2026 Target<\/strong>: $200-225 (25-41% growth potential)<br \/> <em>Rationale: Market recovery + expanded service offerings<\/em><\/li>\n<li><strong>2028 Projection<\/strong>: $280-320 (75-100% long-term gain)<br \/> <em>Rationale: Biotech boom + aging population demand<\/em><\/li>\n<li><strong>2030 Vision<\/strong>: $400-450 (150-180% total return)<br \/> <em>Rationale: Global healthcare expansion + AI integration<\/em><\/li>\n<\/ul>\n<p><strong>Verdict: STRONG BUY<\/strong> for long-term investors. The recent earnings beat and raised guidance signal management confidence despite short-term volatility.<\/p>\n<h2>\u26a0\ufe0f Risk Assessment: What Could Go Wrong?<\/h2>\n<ul>\n<li><strong>Regulatory Risks<\/strong>: FDA&#8217;s plan to reduce animal testing could impact 30% of revenue from Discovery &amp; Safety Assessment segment. This isn&#8217;t hypothetical\u2014it&#8217;s already causing analyst downgrades.<\/li>\n<li><strong>Client Concentration<\/strong>: Major pharmaceutical budget cuts or mergers could reduce contract volumes. When big pharma sneezes, CROs catch colds.<\/li>\n<li><strong>Currency Exposure<\/strong>: 68% revenue from overseas means strong dollar hurts international profits.<\/li>\n<li><strong>Debt Concerns<\/strong>: $2.1 billion debt load requires careful cash flow management during economic uncertainty.<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Positive Signals: Why CRL Could Soar<\/h2>\n<ul>\n<li><strong>Earnings Momentum<\/strong>: Q2 2025 beat by 24.80% shows operational excellence<\/li>\n<li><strong>Contract Wins<\/strong>: Multiple large-scale renewals with global biopharma clients<\/li>\n<li><strong>Industry Trend<\/strong>: Outsourced research growing at 8% annually as pharma cuts costs<\/li>\n<li><strong>Digital Transformation<\/strong>: Lab automation investments improving margins<\/li>\n<li><strong>Defensive Business<\/strong>: Essential services regardless of economic conditions<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Recent News Impact: August 2025 Analysis<\/h2>\n<p>Charles River has been busy in 2025! The company secured several strategic partnerships, including an expanded collaboration with a leading biotech firm to develop advanced drug development models. These deals aren&#8217;t just press releases\u2014they represent future revenue streams that could drive growth for years.<\/p>\n<p>Most importantly, management reaffirmed full-year guidance despite macroeconomic challenges. When executives put their reputation behind forecasts during uncertain times, it&#8217;s usually a good sign.<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2>\n<ol>\n<li><strong>Start Small<\/strong>: Buy 1-2 shares to get skin in the game without overexposure<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Add $100 monthly regardless of price fluctuations<\/li>\n<li><strong>Set Price Alerts<\/strong>: Buy more if stock drops to $150 support level<\/li>\n<li><strong>Patience Pays<\/strong>: This is a 3-5 year investment, not a weekly trade<\/li>\n<li><strong>Humorous Reality Check<\/strong>: &#8220;Trading CRL is like watching paint dry\u2014until suddenly it&#8217;s a masterpiece. Bring snacks.&#8221;<\/li>\n<\/ol>\n<h2>\u2705 How to Buy Charles River Laboratories International, Inc. (CRL) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose Trading Platform<\/td>\n<td>Ensure it offers NYSE stocks and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete Account Funding<\/td>\n<td>Start with $50-100 to test waters<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Search &#8220;CRL&#8221;<\/td>\n<td>Use ticker symbol, not company name<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Select Order Type<\/td>\n<td>Use limit order around $158-161 for better entry<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Review and Execute<\/td>\n<td>Check commission fees\u2014aim for &lt;1% transaction cost<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Set Portfolio Allocation<\/td>\n<td>Keep CRL at 5-10% of total portfolio for diversification<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Enable Price Alerts<\/td>\n<td>Get notified at key support\/resistance levels<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Document Your Thesis<\/td>\n<td>Write down why you bought for future reference<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Regular Review<\/td>\n<td>Check quarterly earnings, not daily price movements<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Reinvest Dividends<\/td>\n<td>CRL doesn&#8217;t pay dividends, but plan for compounding<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Makes Sense for CRL Investors<\/h2>\n<p>Pocket Option offers unique advantages for Charles River Laboratories investors:<\/p>\n<ul>\n<li><strong>Minimum Deposit Just $5<\/strong> &#8211; Perfect for testing strategies with small positions<\/li>\n<li><strong>Lightning-Fast KYC<\/strong> &#8211; Upload any ID document and start trading in minutes<\/li>\n<li><strong>100+ Withdrawal Methods<\/strong> &#8211; Crypto, e-wallets, bank cards\u2014your profit, your choice<\/li>\n<li><strong>Fractional Shares Available<\/strong> &#8211; Buy pieces of CRL without full share price<\/li>\n<li><strong>Real-Time NYSE Data<\/strong> &#8211; Accurate pricing for informed decisions<\/li>\n<\/ul>\n<p>For new investors, this accessibility means you can build a position in CRL gradually without needing thousands upfront.<\/p>\n<h2>\ud83c\udf0d Charles River Laboratories in 2025: The Invisible Pharma Giant<\/h2>\n<p>Charles River isn&#8217;t a household name, but it should be. This company has been involved in <strong>80% of FDA-approved drugs<\/strong> over the past five years\u2014that&#8217;s virtually every major medication reaching patients. Founded in 1947, CRL has evolved from animal research provider to comprehensive drug development partner serving pharmaceutical giants worldwide.<\/p>\n<p>The company operates three core segments: Research Models &amp; Services, Discovery &amp; Safety Assessment, and Manufacturing Support. Their 20,100 employees work across global laboratories, helping accelerate treatments for everything from cancer to rare diseases.<\/p>\n<p><strong>2025 Interesting Fact<\/strong>: Charles River&#8217;s scientists recently developed a breakthrough AI-powered drug discovery platform that can predict compound effectiveness with 92% accuracy\u2014cutting research time from years to months and potentially saving billions in development costs.<\/p>\n"},"faq":[{"question":"Is CRL stock a good long-term investment?","answer":"Absolutely. With involvement in 80% of new drugs and essential services regardless of economic conditions, CRL offers defensive growth potential. The aging population and biotech innovation tailwinds support long-term upside."},{"question":"What's the biggest risk with CRL stock?","answer":"Regulatory changes around animal testing pose the most significant threat. The FDA's initiative to reduce animal testing could impact their core Discovery segment revenue if not adapted to quickly."},{"question":"How often does CRL report earnings?","answer":"Quarterly\u2014typically February, May, August, and November. These dates create volatility opportunities for attentive investors."},{"question":"Does Charles River pay dividends?","answer":"No, CRL reinvests all profits into growth initiatives, acquisitions, and debt reduction rather than paying dividends."},{"question":"What price should I buy CRL stock?","answer":"Between $150-165 offers reasonable value based on current earnings multiples. Use dollar-cost averaging rather than trying to time the perfect entry."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is CRL stock a good long-term investment?","answer":"Absolutely. With involvement in 80% of new drugs and essential services regardless of economic conditions, CRL offers defensive growth potential. The aging population and biotech innovation tailwinds support long-term upside."},{"question":"What's the biggest risk with CRL stock?","answer":"Regulatory changes around animal testing pose the most significant threat. The FDA's initiative to reduce animal testing could impact their core Discovery segment revenue if not adapted to quickly."},{"question":"How often does CRL report earnings?","answer":"Quarterly\u2014typically February, May, August, and November. These dates create volatility opportunities for attentive investors."},{"question":"Does Charles River pay dividends?","answer":"No, CRL reinvests all profits into growth initiatives, acquisitions, and debt reduction rather than paying dividends."},{"question":"What price should I buy CRL stock?","answer":"Between $150-165 offers reasonable value based on current earnings multiples. Use dollar-cost averaging rather than trying to time the perfect entry."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Charles River Laboratories International, Inc. (CRL) shares - Investment in Charles River Laboratories International, Inc. (CRL) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Charles River Laboratories International, Inc. (CRL) shares - Investment in Charles River Laboratories International, Inc. (CRL) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T10:27:19+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Charles River Laboratories International, Inc. (CRL) shares &#8211; Investment in Charles River Laboratories International, Inc. (CRL) stock\",\"datePublished\":\"2025-08-28T10:27:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\",\"name\":\"How to buy Charles River Laboratories International, Inc. (CRL) shares - Investment in Charles River Laboratories International, Inc. (CRL) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-28T10:27:19+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Charles River Laboratories International, Inc. (CRL) shares &#8211; Investment in Charles River Laboratories International, Inc. (CRL) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Charles River Laboratories International, Inc. (CRL) shares - Investment in Charles River Laboratories International, Inc. (CRL) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Charles River Laboratories International, Inc. (CRL) shares - Investment in Charles River Laboratories International, Inc. (CRL) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T10:27:19+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Charles River Laboratories International, Inc. (CRL) shares &#8211; Investment in Charles River Laboratories International, Inc. (CRL) stock","datePublished":"2025-08-28T10:27:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/","name":"How to buy Charles River Laboratories International, Inc. (CRL) shares - Investment in Charles River Laboratories International, Inc. (CRL) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-28T10:27:19+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Charles River Laboratories International, Inc. (CRL) shares &#8211; Investment in Charles River Laboratories International, Inc. (CRL) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":354039,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"Comment acheter des actions de Charles River Laboratories International, Inc. (CRL) - Investissement dans les actions de Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"it_IT":{"locale":"it_IT","id":354041,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"Come acquistare azioni Charles River Laboratories International, Inc. (CRL) - Investimento in azioni Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"pl_PL":{"locale":"pl_PL","id":354042,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"Jak kupi\u0107 akcje Charles River Laboratories International, Inc. (CRL) - Inwestycja w akcje Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"es_ES":{"locale":"es_ES","id":354036,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"C\u00f3mo comprar acciones de Charles River Laboratories International, Inc. (CRL) - Inversi\u00f3n en acciones de Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"th_TH":{"locale":"th_TH","id":354037,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Charles River Laboratories International, Inc. (CRL) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"tr_TR":{"locale":"tr_TR","id":354038,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"Charles River Laboratories International, Inc. (CRL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Charles River Laboratories International, Inc. (CRL) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"vt_VT":{"locale":"vt_VT","id":354043,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Charles River Laboratories International, Inc. (CRL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"},"pt_AA":{"locale":"pt_AA","id":354040,"slug":"how-to-buy-charles-river-laboratories-international","post_title":"Como comprar a\u00e7\u00f5es da Charles River Laboratories International, Inc. (CRL) - Investimento em a\u00e7\u00f5es da Charles River Laboratories International, Inc. (CRL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-charles-river-laboratories-international\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/353930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=353930"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/353930\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=353930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=353930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=353930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}